Design Therapeutics, Inc. · NASDAQ:DSGN
SR One Capital Fund I Aggregator, LP reported a 10.60% stake in Design Therapeutics, Inc. (Schedule 13D/A)
Event Mar 9, 2026 · Filed Mar 11, 2026
SR One Capital Fund I Aggregator, LP reported a 10.60% stake in Design Therapeutics, Inc., 6,526,476 shares, with active intent on Mar 9, 2026. Filed Mar 11, 2026 (Schedule 13D/A).
- Stake
- 10.60%
- Shares
- 6,526,476
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SR One Capital Fund I Aggregator, LP | 10.60% | 6,526,476 |
| SR One Capital Partners I, LP | 10.60% | 6,526,476 |
| SR One Capital Management, LLC | 10.60% | 6,526,476 |
| Simeon George | 10.70% | 6,607,892 |
Source
Related
- Design Therapeutics, Inc.
- SR One Capital Fund I Aggregator, LP
- Design Therapeutics, Inc. shareholders
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jun 9, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026